Long-Acting Treatment in Adolescents (LATA)

NCT05154747 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

476

Enrollment

OTHER

Sponsor class

Conditions

Hiv
HIV Infections
HIV-1-infection
Paediatric Human Immunodeficiency Virus Infection

Interventions

DRUG: Cabotegravir, Rilpivirine Drug Combination
DRUG: TLD

Sponsor

University College, London

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]